Classical pathway complement activity in schizophrenia
Section snippets
Acknowledgements
We thank the staff of Nubarashen Psychiatric Hospital, especially Dr. Maya Melkumova, for their kind support.
References (24)
- et al.
GSK-3 and the neurodevelopmental hypothesis of schizophrenia
Eur. Neuropsychopharmacol.
(2002) - et al.
Phylogeny and diversity of the third complement component C3
Dev. Comp. Immunol.
(1997) - et al.
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
Psychiatry Res.
(1997) - et al.
The possible role of plasma kallikrein-kinin system and leukocyte elastase in pathogenesis of schizophrenia
Immunopharmacology
(1999) - et al.
Acute phase proteins in male Chinese schizophrenic patients in Singapore
Schizophr. Res.
(1996) - et al.
The systemic reaction during inflammation: the acute-phase proteins
Protein Pept. Lett.
(2002) Purification of complement component
- et al.
Complement genetic markers in schizophrenia: C3, BF and C6 polymorphisms
Hum. Hered.
(1992) - et al.
Haloperidol-induced neurotoxicity-possible implications for tardive dyskinesia
J. Neural Transm.
(2000) - et al.
Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms
Cell. Mol. Neurobiol.
(2001)
Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation
Am. J. Psychiatry
(2004)
Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates
Cited by (0)
Copyright © 2004 Elsevier Ireland Ltd. All rights reserved.